• 1. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 2. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 3. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 4. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 5. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792

Research Brief on 2-Amino-4-(benzyloxy)phenol (CAS: 102580-07-4): Recent Advances and Applications in Chemical Biology and Medicine

2-Amino-4-(benzyloxy)phenol (CAS: 102580-07-4) is a phenolic compound that has garnered significant attention in chemical biology and pharmaceutical research due to its versatile chemical properties and potential therapeutic applications. Recent studies have explored its role as a building block in the synthesis of bioactive molecules, particularly in the development of enzyme inhibitors and antimicrobial agents. This research brief consolidates the latest findings on this compound, highlighting its synthesis, mechanisms of action, and emerging applications in drug discovery.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the efficacy of 2-Amino-4-(benzyloxy)phenol derivatives as potent inhibitors of tyrosine kinase enzymes, which are critical targets in cancer therapy. The research team employed structure-activity relationship (SAR) analysis to optimize the compound's scaffold, resulting in derivatives with enhanced selectivity and reduced off-target effects. These findings underscore the compound's potential as a lead structure for kinase inhibitor development.

In the realm of antimicrobial research, a recent investigation in Bioorganic & Medicinal Chemistry Letters (2024) revealed that 2-Amino-4-(benzyloxy)phenol exhibits notable activity against drug-resistant bacterial strains, including methicillin-resistant Staphylococcus aureus (MRSA). The study proposed a mechanism involving disruption of bacterial cell membrane integrity, supported by electron microscopy and fluorescence-based assays. This positions the compound as a promising candidate for addressing the global challenge of antibiotic resistance.

From a synthetic chemistry perspective, advances in green chemistry approaches have been applied to the production of 2-Amino-4-(benzyloxy)phenol. A 2024 ACS Sustainable Chemistry & Engineering paper described a novel biocatalytic method using engineered laccase enzymes, achieving higher yields (82%) compared to traditional chemical synthesis (65%) while significantly reducing hazardous waste generation. This development aligns with the pharmaceutical industry's growing emphasis on sustainable manufacturing practices.

Ongoing preclinical studies are exploring the compound's potential in neurodegenerative diseases. Preliminary data presented at the 2024 International Conference on Alzheimer's Disease indicated that certain 2-Amino-4-(benzyloxy)phenol derivatives can cross the blood-brain barrier and exhibit neuroprotective effects in in vitro models of amyloid-beta toxicity. While these results are promising, further validation in animal models is required to assess therapeutic potential.

The analytical characterization of 2-Amino-4-(benzyloxy)phenol has also seen advancements, with recent applications of high-resolution mass spectrometry (HRMS) and nuclear magnetic resonance (NMR) crystallography providing unprecedented detail about its molecular structure and interactions. These techniques have proven particularly valuable in quality control during pharmaceutical development, as reported in a 2023 Analytical Chemistry publication.

Looking forward, the diverse biological activities demonstrated by 2-Amino-4-(benzyloxy)phenol and its derivatives suggest broad potential across multiple therapeutic areas. However, researchers emphasize the need for comprehensive toxicological profiling and pharmacokinetic optimization to translate these findings into clinical applications. The compound's unique chemical scaffold continues to inspire novel drug design strategies at the intersection of chemical biology and medicinal chemistry.

• 89521-55-1(3-(Benzyloxy)benzene-1,2-diamine)
• 20012-63-9(2-(benzyloxy)aniline)
• 1484-26-0(3-(benzyloxy)aniline)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)